New Delhi: Drug major Ranbaxy Laboratories today said it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market."Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories Ltd, has resumed the supply of Atorvastatin calcium tablets that includes 10 mg, 20 mg, 40 mg and 80 mg dosage strengths to the US market," Ranbaxy Laboratories said in a BSE filing. The company had stopped production of generic version of cholesterol lowering drug Lipitor last year as it investigated the issue of potential glass particles in certain lots of the drug. On November 9, 2012, Ranbaxy had informed customers of a voluntary recall of certain lots of the company`s 10mg, 20mg, and 40mg dosage strengths of atorvastatin tablets from the US market.
Rahul Gandhi addresses FICCI meet
Is AAP afraid to form a govt?
Adarsh scam: A tale of greed and nepotism?
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi